Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Triple Negative Breast Cancer
Interventions: OTHER: Chemotherapy
Sponsor: Icahn School of Medicine at Mount Sinai
Collaborators: Champions Oncology